Why Curaleaf Stock Is Crushing It Today

Curaleaf Holdings (OTC: CURLF) shares surged over 13% on Monday, extending a more than 20% rally since its Q2 earnings release, despite reporting an 8% year-over-year net revenue decline to $314.5 billion and a widened net loss. This positive market reaction stems from investor focus on signs of stabilization in the U.S. cannabis market, evidenced by sequential domestic revenue growth, and robust momentum in its international segment, further bolstered by a new license in Turkey. The stock's performance indicates investor emphasis on future growth vectors, particularly international expansion, overshadowing current unprofitability.

Analysis

Despite a significant stock price surge of over 20% since its Q2 update, Curaleaf Holdings' underlying financials show considerable weakness. The company reported an 8% year-over-year decline in net revenue to $314.5 billion, a widened net loss from continuing operations to $50.6 million, and a 9.7% drop in adjusted EBITDA to $65.5 million. The market's positive reaction appears to disregard these deteriorating metrics, focusing instead on forward-looking indicators. Investors are prioritizing two key narratives: signs of stabilization in the critical U.S. market, evidenced by a sequential increase in domestic revenue from Q1 2025, and strong momentum in its international business. This international growth outlook is further supported by the company's recent acquisition of its minority partner in Curaleaf International and its new license to operate in Turkey. However, a significant disconnect exists between the stock's momentum and its fundamental performance, as the company remains unprofitable and still faces headwinds in the U.S., which constitutes 87% of its total revenue.

Key Decisions for Investors

• Investors should weigh the stock's strong price momentum against its weak year-over-year fundamental performance, recognizing the current rally is based on future growth expectations rather than current profitability.
• Monitor upcoming quarterly reports for tangible evidence that sequential U.S. revenue stabilization and international expansion can reverse the negative trends in profitability and overall revenue growth.
• Given the company's unprofitability and reliance on the U.S. market, consider the high-risk nature of the investment and the potential for volatility if market sentiment shifts or growth catalysts fail to materialize as anticipated.